Overview of targeted therapies for cancer
1Department of Pharmacy Practice and Pharmacy Administration, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, 600 South 43rd Street, Philadelphia, PA 19104-4495, USA. r.finley@usip.edu
Abstract:
Targeted therapies for cancer are discussed. Research into the molecular biology of cancer has revealed critical differences between normal and tumor cells and has pinpointed key processes that regulate the growth and progression of cancers. This has in turn allowed for the development of agents that specifically target these molecules and pathways, particularly those regulating the signaling transduction pathway that controls cell replication, differentiation, tumor metastasis, and apoptosis. Such novel targeted therapies include those that can inhibit the function of cellular growth factors or their receptors essential for signal transduction, block angiogenesis required for tumor growth and metastasis, and antisense strategies designed to suppress the expression of specific genes. These approaches have resulted in clinical benefit for selected tumor types, yet challenges remain such as determining the optimal dose and administration of these agents, alone or in combination with standard cytotoxic chemotherapy, and at what stage of disease they might have the greatest influence.
Insights
Targeted cancer therapies leverage molecular biology insights to develop agents that inhibit tumor growth pathways. These novel treatments show clinical benefit but require further research on optimal dosing and application.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Cancer research has identified key molecular differences between normal and tumor cells.
- Understanding these differences enables the development of targeted therapeutic strategies.
- Key cellular processes regulated by signaling transduction pathways are critical in cancer progression.
Purpose of the Study:
- To discuss novel targeted therapies for cancer.
- To highlight agents that target specific molecules and pathways regulating cancer growth.
- To review challenges and future directions in targeted cancer therapy.
Main Methods:
- Inhibition of cellular growth factor signaling.
- Blocking of angiogenesis essential for tumor growth and metastasis.
- Antisense strategies to suppress specific gene expression.
Main Results:
- Targeted therapies have demonstrated clinical benefit in specific cancer types.
- These therapies target critical pathways such as cell replication, differentiation, metastasis, and apoptosis.
- Novel agents include growth factor inhibitors, anti-angiogenic drugs, and gene expression suppressors.
Conclusions:
- Targeted therapies represent a significant advancement in cancer treatment.
- Optimal dosing, administration, and disease stage for maximum influence require further investigation.
- Combination strategies with standard chemotherapy warrant further study.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...